Fact CheckerSign in

NCT06368479Completed

Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Source: ClinicalTrials.gov · Last updated 21 Feb 2025

Brief summary (registry, in English)

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.

Status (registry)
Completed
Study type
Interventional
Enrollment
1400 (actual)
First submitted
10 Apr 2024
Start date
19 Mar 2024
Primary completion date
19 Jul 2024
Lead sponsor
bioLytical Laboratories
Diseases
Hepatitis B
NCT number
NCT06368479

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1400
  • From 19 Mar 2024 to the primary completion date, 19 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Participant younger than 18 years old

Other

  • Participants unable to provide written informed consent

Who the study is looking for

  • Participants/subjects (males, females, and pregnant women) getting tested for Hepatitis B virus for one or more of the following reasons:
    • at risk for Hepatitis B virus
    • having signs and symptoms indicative for Hepatitis B virus
    • Routine testing Unknown or other reasons will be captured
  • Participants/subjects of 18 years or older and, who are able to give/sign the informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Epicentre Health Research
Coordinator of this site? Confirm its status
HillcrestSouth AfricaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.